Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
Caterina Pont, Tiziana Ginex, Christian Griñán‐Ferré, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113779-113779
Open Access | Times Cited: 13

Showing 13 citing articles:

Acetylcholinesterase: A Versatile Template to Coin Potent Modulators of Multiple Therapeutic Targets
F. Javier Luque, Diego Muñoz‐Torrero
Accounts of Chemical Research (2024)
Open Access | Times Cited: 18
Practical Three-Component Regioselective Synthesis of Drug-Like 3-Aryl(or heteroaryl)-5,6-dihydrobenzo[h]cinnolines as Potential Non-Covalent Multi-Targeting Inhibitors To Combat Neurodegenerative Diseases
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 9, pp. 1828-1881
Closed Access | Times Cited: 8
Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease
Sandra Codony, Caterina Pont, Christian Griñán‐Ferré, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 6, pp. 4909-4925
Open Access | Times Cited: 37
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Synthesis of new N‐(5,6‐methylenedioxybenzothiazole‐2‐yl)‐2‐[(substituted)thio/piperazine]acetamide/propanamide derivatives and evaluation of their AChE, BChE, and BACE‐1 inhibitory activities
Beyzanur Tutuş, Aybüke Züleyha Kaya, Yonca Baz, et al.
Drug Development Research (2024) Vol. 85, Iss. 4
Open Access | Times Cited: 2
BACE1 inhibitors: A promising therapeutic approach for the management of Alzheimer’s disease
Richa Arya, Smita Jain, Sarvesh Paliwal, et al.
Asian Pacific Journal of Tropical Biomedicine (2024) Vol. 14, Iss. 9, pp. 369-381
Open Access | Times Cited: 2
Selected Natural Products in Neuroprotective Strategies for Alzheimer’s Disease—A Non-Systematic Review
Karolina Wojtunik‐Kulesza, Tomasz Oniszczuk, Jarosław Mołdoch, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1212-1212
Open Access | Times Cited: 10
Novel quinoline-based derivatives: A new class of PDE4B inhibitors for adjuvant-induced arthritis
Siqi Xing, Weizheng Fan, Junhua Chen, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114497-114497
Closed Access | Times Cited: 10
Screening of Multitarget-Directed Natural Compounds as Drug Candidates for Alzheimer’s Disease Using In Silico Techniques: Their Extraction and In Vitro Validation
Sukriti Srivastava, Shilpa Sharma, Shashank Deep, et al.
ACS Omega (2023) Vol. 8, Iss. 41, pp. 38118-38129
Open Access | Times Cited: 5
Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase
İlçim Ceyhun, Şevval Karaca, Derya Osmani̇ye, et al.
Archiv der Pharmazie (2021) Vol. 355, Iss. 3
Closed Access | Times Cited: 11
In vitro and in vivo biological evaluation of newly synthesized multi-target 20(R)-panaxadiol derivatives for treating Alzheimer's disease
Lei Pang, Jin Li, Zheng Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114825-114825
Closed Access | Times Cited: 7
Discovery of new 4-aminoquinoline derivatives containing an amine or hydroxamic acid terminal as multifunctional agents for the treatment of Alzheimer’s disease
Bochao Zhai, Qianyun Hao, Ming-Fan Wang, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107954-107954
Closed Access
Quinindoline-Based Hybrid Compounds as New Inhibitors of Acetylcholinesterase: An In Vitro and Molecular Dynamics Simulations Study
Anita Abedi, Mehdi Pordel, Mohammad Reza Bozorgmehr, et al.
Russian Journal of General Chemistry (2024) Vol. 94, Iss. 10, pp. 2730-2742
Closed Access
Page 1

Scroll to top